Gene · 7706
Papers2,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CircRHBDD1 promotes immune escape via IGF2BP2/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer. | J Transl Med | 2024 | 39080693 | PubTator, text mining | PubMed |
| Evaluation of the Centers for Disease Control and Prevention's Essentials for Parenting Toddlers and Preschoolers on parent behavioral outcomes. | Child Abuse Negl | 2024 | 39032355 | PubTator, text mining | PubMed |
| PRRSV NSP1α degrades TRIM25 through proteasome system to inhibit host antiviral immune response. | Vet Microbiol | 2024 | 38971119 | PubTator, text mining | PubMed |
| Synthesis and in silico studies of certain benzo[f]quinoline-based heterocycles as antitumor agents. | Sci Rep | 2024 | 38969677 | PubTator, text mining | PubMed |
| Exploring the impression of TRIM25 gene expression on COVID-19 severity and SARS-CoV-2 viral replication. | J Infect Public Health | 2024 | 38964175 | PubTator, text mining | PubMed |
| Neddylation activated TRIM25 desensitizes triple-negative breast cancer to paclitaxel via TFEB-mediated autophagy. | J Exp Clin Cancer Res | 2024 | 38926803 | PubTator, text mining | PubMed |
| Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics. | Sci Rep | 2024 | 38902252 | PubTator, text mining | PubMed |
| TRIM25-mediated XRCC1 ubiquitination accelerates atherosclerosis by inducing macrophage M1 polarization and programmed death. | Inflamm Res | 2024 | 38896288 | PubTator, text mining | PubMed |
| Circ6834 suppresses non-small cell lung cancer progression by destabilizing ANHAK and regulating miR-873-5p/TXNIP axis. | Mol Cancer | 2024 | 38890620 | PubTator, text mining | PubMed |
| Molecular screening of phytocompounds targeting the interface between influenza A NS1 and TRIM25 to enhance host immune responses. | J Infect Public Health | 2024 | 38815532 | PubTator, text mining | PubMed |
| USP25 Elevates SHLD2-Mediated DNA Double-Strand Break Repair and Regulates Chemoresponse in Cancer. | Adv Sci (Weinh) | 2024 | 38803048 | PubTator, text mining | PubMed |
| Structural basis of pri-let-7 recognition by human pseudouridine synthase TruB1. | Biochem Biophys Res Commun | 2024 | 38776834 | PubTator, text mining | PubMed |
| Targeting SOX13 inhibits assembly of respiratory chain supercomplexes to overcome ferroptosis resistance in gastric cancer. | Nat Commun | 2024 | 38769295 | PubTator, text mining | PubMed |
| Enhancement of N-Methyl Amino Acid Incorporation into Proteins and Peptides Using Modified Bacterial Ribosomes and Elongation Factor P. | ACS Chem Biol | 2024 | 38769080 | PubTator, text mining | PubMed |
| TRIM25 predominately associates with anti-viral stress granules. | Nat Commun | 2024 | 38750080 | PubTator, text mining | PubMed |
| TRIM38 Induced in Respiratory Syncytial Virus-infected Cells Downregulates Type I Interferon Expression by Competing with TRIM25 to Bind RIG-I. | Inflammation | 2024 | 38630167 | PubTator, text mining | PubMed |
| Swine acute diarrhea syndrome coronavirus nucleocapsid protein antagonizes the IFN response through inhibiting TRIM25 oligomerization and functional activation of RIG-I/TRIM25. | Vet Res | 2024 | 38589930 | PubTator, text mining | PubMed |
| Viral deubiquitinating proteases and the promising strategies of their inhibition. | Virus Res | 2024 | 38588924 | PubTator, text mining | PubMed |
| Fine-tuning the tRNA anticodon arm for multiple/consecutive incorporations of β-amino acids and analogs. | Nucleic Acids Res | 2024 | 38572748 | PubTator, text mining | PubMed |
| Targeting MicroRNAs with Small Molecules. | Noncoding RNA | 2024 | 38525736 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7706/papers?page=11